{
    "author": [], 
    "text": "Researchers have uncovered a novel mechanism behind the ability of the diabetes drug metformin to inhibit the progression of pancreatic cancer.\n\nResearchers found that metformin decreases the inflammation and fibrosis characteristic of the most common form of pancreatic cancer. The findings indicate that this beneficial effect may be most prevalent in overweight and obese patients.\n\nThe study by researchers at Massachusetts General Hospital (MGH) focused on pancreatic ductal adenocarcinoma, the most common form of pancreatic cancer.\n\nThe study was published in PLOS One . \u2014 PTI", 
    "section": "national", 
    "title": "Diabetes drug may slow growth of pancreatic cancer: study", 
    "subsection": "general", 
    "date": "2016-01-18"
}